Question 1

WHAT IS XOFIGO?

Accepted Answer

Xofigo is Radium 223 Dichloride and is an alpha particle-emitting radioactive therapeutic agent. It is used for treatment of patient with prostate cancer.

Question 2

WHO IS XOFIGO SUITABLE FOR?

Accepted Answer

Xofigo is suitable for metastatic castration-resistant prostate cancer (mCRPC) patient on second-generation hormonal therapy has: • Bone metastases, and no visceral metastases • Suspected disease progression: — Increase in biomarker levels, such as prostate-specific antigen (PSA) and/or alkaline phosphatase (ALP) — Progression seen on imaging scans — Emerging symptoms (use of analgesics)

Question 3

HOW LONG IS THE XOFIGO TREATMENT?

Accepted Answer

• Treatment plan: 6 injections total • Slow intravenous (IV) injection over 1 minute • Treatment can be completed in 5 months • Patients may return home after the injection

Question 4

WHAT DO I NEED TO BRING FOR TREATMENT?

Accepted Answer

ID and/or Passport. 
This original Preparation Instruction Sheet 
Previous/recent relevant reports or CD, if available. 
Previous / recent blood test results, if available. 
DO NOT bring valuable belongings, including jewellery, etc   SPECIAL ARRANGEMENT If patients are on wheel chair / trolley, please come with: Accompanying staff nurse familiar with patients' medical background Existing IV line / cannula, if any Urine bag, where applicable, should be emptied. Parking for ambulances are available at Level B2 carpark. 
Urinal / bedpan / extra diapers when necessary for toileting care.

Blog

Blog

Blog